Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas

Pediatric Blood and Cancer

Volumn 47, Issue 1, 2006, Pages 37-41

  Korones, David N ^a   Smith, Amy ^b   Foreman, Nicholas ^c   Bouffet, Eric ^d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Etoposide; Malignant glioma; Recurrent; Temozolomide; Treatment induced; VP 16

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; LOMUSTINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ADULT DISEASE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EXPOSURE; DRUG RESPONSE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MOUTH ULCER; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; VIRUS INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DACARBAZINE; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646877529     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20510     Document Type: Article

References (30)

1. Finlay JL, Wisoff JH. The impact of extent of resection in the management of malignant gliomas of childhood. Child's Nerv Syst 1999;15:786-788.
2. Finlay JL, Boyett JM, Yates AJ, et al. A randomized phase III trial in childhood high grade astrocytoma comparing vincristine, CCNU, and prednisone with the "eight-drugs-in-one-day regimen: A report of the Childrer"s Cancer Group Trial CCG-945. J Clin Oncol 1995;13:112-123.
3. Finlay JL, Goldman S, Wong MC, et al. A pilot study of high dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent central nervous system tumors. J Clin Oncol 1996;14:2495-2503.
4. Hodgson DC, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain tumors. Int J Rad Oncol Biol Phys 2001;50:929-935.
5. Maluf CF, Deangelis LM, Raizer JJ, et al. High-grade gliomas in patients with prior systemic malignancies. Cancer 2002;94:3219-3224.
6. Leung W, Ribeiro RC, Hudson M, et al. Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia 2001; 15:41-45.
7. Stragliotto G, Packer RJ, Rausen AR, et al. Letter to the Editor: Outcome of post-radiation secondary glioblastoma in children. Med Pediatr Oncol 1998;30:194-195.
8. Gilbert MR, Friedman HS, Kuttesch JF, et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro-Oncology 2002; 4:261-267.
9. Yung WK, Albright RE, Olson J, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000;83:588-593.
10. Nicholson HS, Krailo M, Ames MM, et al. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: A report from the Children's Cancer Group. J Clin Oncol 1998;16:3037-3043.
11. Estlin EJ, Lashford L, Ablett S, et al. Phase 1 study of temozolomide in paediatric patients with advanced cancer. Br J Cancer 1998;78:652-661.
12. Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 2002;20:4684-4691.
13. Needle MN, Molloy PT, Geyer JR, et al. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 1997;29:28-32.
14. Ashley DM, Meier L, Kerby T, et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 1996;14: 1922-1927.
15. Chamberlain MC. Recurrent intracranial ependymoma in children: Salvage therapy with oral etoposide. Pediatr Neurol 2001;24:117-121.
16. Chamberlain MC. Recurrent supratentorial malignant gliomas in children; long-term salvage therapy with oral etoposide. Arch Neurol 1997;54:554-558.
17. Chamberlain MC. Recurrent brainstem gliomas treated with oral VP.16. J Neurooncol 1993;15:133-139.
18. Chamberlain MC, Jaekle KA. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 1995;13:2072-2076.
19. Korones DN, Fisher PG, Cohen JK, et al. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol 2000;35:80-82.
20. Lilley ER. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft. Cancer Res 1990;50:284-287.
21. Patel VJ, Elion GB, Houghton PJ, et al. Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. Clin Cancer Res 2000; 6:4154-4157.
22. Wagner LM, Crews KR, Iacono LC, et al. Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors. Clin Cancer Res 2004;10:840-848.
23. Gruber ML, Buster WP. Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma. Am J Clin Oncol 2004;27:33-38.
24. Korones DN, Weiss MB, Coyle TE, et al. A phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant gliomas. Cancer 2003;97:1963-1968.
25. Korones DN, Benita-Weiss M, Coyle TE, et al. A Phase II study of temozolomide and oral VP-16 for adults with recurrent malignant glioma. Proc ASCO 2003;22:447a.
26. McDonald DR, Cacino TL, Schold SC, et al. Response criteria for Phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
27. Verschuur AC, Grill J, Lelouch-Tubiana A, et al. Temozolomide in paediatric high-grade glioma: A key for combination therapy?. Br J Cancer 2004;91:425-429.
28. Stavrou TS, Bromley CM, Nicholson SH, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol/Oncol 2001;23:431-436.
29. Salvati M, Fratti A, Russo N, et al. Radiation-induced gliomas: Report of 10 cases and review of the literature. Surg Neurol 2003;60:60-67.
30. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999;354:34-39.